Royal London Asset Management’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $348M | Sell |
2,896,154
-300,997
| -9% | -$34.7M | 0.73% | 18 |
|
|
2025
Q4 | $337M | Sell |
3,197,151
-2,720
| -0.1% | -$255K | 0.71% | 17 |
|
|
2025
Q3 | $269M | Sell |
3,199,871
-206,475
| -6% | -$17M | 0.58% | 26 |
|
|
2025
Q2 | $270M | Sell |
3,406,346
-45,210
| -1% | -$3.59M | 0.62% | 21 |
|
|
2025
Q1 | $310M | Buy |
3,451,556
+2,190,512
| +174% | +$205M | 0.73% | 21 |
|
|
2024
Q4 | $125M | Buy |
1,261,044
+4,002
| +0.3% | +$413K | 0.31% | 60 |
|
|
2024
Q3 | $143M | Buy |
1,257,042
+63,061
| +5% | +$7.49M | 0.35% | 56 |
|
|
2024
Q2 | $148M | Buy |
1,193,981
+51,198
| +4% | +$6.59M | 0.38% | 54 |
|
|
2024
Q1 | $151M | Sell |
1,142,783
-1,011
| -0.1% | -$125K | 0.38% | 55 |
|
|
2023
Q4 | $125M | Buy |
1,143,794
+23,830
| +2% | +$2.47M | 0.36% | 57 |
|
|
2023
Q3 | $115M | Buy |
1,119,964
+55,012
| +5% | +$5.93M | 0.37% | 55 |
|
|
2023
Q2 | $123M | Buy |
1,064,952
+148,727
| +16% | +$16.9M | 0.4% | 50 |
|
|
2023
Q1 | $97.5M | Buy |
916,225
+21,653
| +2% | +$2.34M | 0.39% | 52 |
|
|
2022
Q4 | $99.2M | Buy |
894,572
+21,693
| +2% | +$2.22M | 0.44% | 45 |
|
|
2022
Q3 | $75.2M | Sell |
872,879
-54,262
| -6% | -$4.84M | 0.38% | 51 |
|
|
2022
Q2 | $84.7M | Buy |
927,141
+4,180
| +0.5% | +$371K | 0.39% | 54 |
|
|
2022
Q1 | $75.7M | Buy |
922,961
+44,009
| +5% | +$3.47M | 0.3% | 64 |
|
|
2021
Q4 | $67.4M | Sell |
878,952
-27,826
| -3% | -$2.22M | 0.25% | 79 |
|
|
2021
Q3 | $68.1M | Sell |
906,778
-9,116
| -1% | -$693K | 0.28% | 73 |
|
|
2021
Q2 | $71.2M | Sell |
915,894
-59,211
| -6% | -$4.4M | 0.29% | 72 |
|
|
2021
Q1 | $71.7M | Buy |
975,105
+8,242
| +0.9% | +$608K | 0.33% | 68 |
|
|
2020
Q4 | $75.4M | Sell |
966,863
-51,074
| -5% | -$3.91M | 0.4% | 58 |
|
|
2020
Q3 | $79.5M | Sell |
1,017,937
-5,867
| -0.6% | -$460K | 0.48% | 45 |
|
|
2020
Q2 | $74.4M | Sell |
1,023,804
-37,622
| -4% | -$2.83M | 0.52% | 37 |
|
|
2020
Q1 | $77.9M | Sell |
1,061,426
-7,719
| -0.7% | -$607K | 0.63% | 29 |
|
|
2019
Q4 | $92.9M | Buy |
1,069,145
+11,679
| +1% | +$959K | 0.64% | 28 |
|
|
2019
Q3 | $84.9M | Sell |
1,057,466
-18,952
| -2% | -$1.52M | 0.64% | 28 |
|
|
2019
Q2 | $86.1M | Sell |
1,076,418
-18,028
| -2% | -$1.38M | 0.81% | 22 |
|
|
2019
Q1 | $86.8M | Sell |
1,094,446
-78,668
| -7% | -$5.88M | 0.68% | 24 |
|
|
2018
Q4 | $84.4M | Buy |
1,173,114
+63,596
| +6% | +$4.49M | 0.74% | 24 |
|
|
2018
Q3 | $75.1M | Sell |
1,109,518
-82,851
| -7% | -$5.28M | 0.77% | 24 |
|
|
2018
Q2 | $69.1M | Buy |
+1,192,369
| New | +$67.3M | 0.69% | 26 |
|
|
2016
Q2 | $57.1M | Sell |
1,039,070
-37,270,963
| -97% | -$1.98B | 0.93% | 20 |
|
|
2016
Q1 | $691K | Buy |
38,310,033
+37,189,462
| +3,319% | +$1.82B | 0.99% | 17 |
|
|
2015
Q4 | $56.9M | Buy |
1,120,571
+18,344
| +2% | +$925K | 0.88% | 25 |
|
|
2015
Q3 | $51.9M | Buy |
+1,102,227
| New | +$58.6M | 0.84% | 25 |
|
|
2014
Q4 | $524K | Buy |
952,123
+209,110
| +28% | +$11.7M | 0.99% | 20 |
|
|
2014
Q3 | $42.1M | Buy |
743,013
+29,948
| +4% | +$1.68M | 1.06% | 19 |
|
|
2014
Q2 | $38.1M | Sell |
713,065
-3,203
| -0.4% | -$175K | 0.87% | 22 |
|
|
2014
Q1 | $37.8M | Sell |
716,268
-20,922
| -3% | -$1.08M | 0.88% | 21 |
|
|
2013
Q4 | $35.1M | Sell |
737,190
-7,576
| -1% | -$346K | 0.89% | 18 |
|
|
2013
Q3 | $32.8M | Buy |
744,766
+4,868
| +0.7% | +$222K | 0.88% | 19 |
|
|
2013
Q2 | $33.4M | Buy |
+739,898
| New | +$33M | 0.97% | 18 |
|
Other funds holding MRK
VCM
VPM
Royal London Asset Management's MRK Position: Q1 2026 in Review
Royal London Asset Management reduced its Merck (MRK) stake by 9.4% in Q1 2026, selling an estimated $34.7M and leaving 2,896,154 shares worth $348M. The position accounts for 0.73% of the portfolio, ranked #18.
Royal London Asset Management first reported a position in MRK in Q2 2013 and has held it in 43 quarters since. 3,779 funds tracked by Wall St. Rank hold MRK as of Q1 2026.
- Royal London Asset Management held 2,896,154 shares of Merck worth $348M as of Q1 2026.
- Royal London Asset Management sold 300,997 Merck shares in Q1 2026, an estimated $34.7M.
- Merck made up 0.73% of Royal London Asset Management's portfolio in Q1 2026, its #18 holding.
- Royal London Asset Management first reported a position in Merck in Q2 2013 and has held it in 43 quarters since.
- 3,779 funds tracked by Wall St. Rank held Merck as of Q1 2026.
Based on Royal London Asset Management's 13F filing for Q1 2026, filed 1 May 2026.